AquaBounty Technologies released its interim results for the six months ended June 30 2011. Ronald Stotish, Chief Executive Officer of AquaBounty, commented: “While the approval process has taken longer than anticipated, we strongly believe that the US Food and Drug Administration (FDA) is moving towards a successful conclusion." Read more ...
This blog is written by Martin Little, The Aquaculturists, published and supported by the International Aquafeed Magazine from Perendale Publishers.
This blog is written by Martin Little, The Aquaculturists, published and supported by the International Aquafeed Magazine from Perendale Publishers.
No comments:
Post a Comment